urticaria
Information
- Disease name
- urticaria
- Disease ID
- DOID:1555
- Description
- "A skin disease characterized by skin rash notable for pale red, raised and itchy bumps, located_in the upper dermis." [url:http\://en.wikipedia.org/wiki/Urticaria]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05496465 | Active, not recruiting | Phase 2 | Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares | July 28, 2022 | January 31, 2024 |
| NCT00001150 | Completed | Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers | October 1976 | March 2004 | |
| NCT00130234 | Completed | Phase 2 | Effect of Anti-IgE in Chronic Urticaria | November 2004 | September 2007 |
| NCT05461456 | Completed | Phase 1 | Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% | April 1, 2022 | October 16, 2022 |
| NCT03296358 | Completed | N/A | Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department. | October 1, 2017 | October 31, 2019 |
| NCT03137069 | Completed | Phase 2 | A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU). | May 26, 2017 | October 25, 2019 |
| NCT03101618 | Completed | Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers | August 24, 2016 | November 27, 2016 | |
| NCT02866864 | Completed | Animal Allergy in Korean Veterinary Researcher | August 24, 2016 | September 1, 2016 | |
| NCT02824393 | Completed | Early Phase 1 | Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria | March 3, 2017 | July 15, 2018 |
| NCT00368823 | Completed | Phase 3 | A Trial of Point of Care Information in Ambulatory Pediatrics | November 1999 | December 2003 |
| NCT00385372 | Completed | N/A | Significance of an Elimination and Provocation Diet in Patients With Chronic Urticaria | January 2005 | April 2007 |
| NCT00421109 | Completed | Phase 3 | Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria | July 2006 | July 2007 |
| NCT00525382 | Completed | Phase 3 | Study to Compare the Efficacy and Safety Between Levocetirizine and Loratadine for Chronic Idiopathic Urticaria | August 2003 | March 2004 |
| NCT00541255 | Completed | A Long-Term Examination of Asthma From Childhood Through Adolescence | September 2007 | February 18, 2015 | |
| NCT00723736 | Completed | Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED) | December 2007 | June 2008 | |
| NCT00724698 | Completed | Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria | October 2005 | December 2007 | |
| NCT02671006 | Completed | Monitoring Chronic Urticaria Basophil Irritability by Cytometry | March 2016 | August 31, 2017 | |
| NCT00751218 | Completed | Phase 4 | A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735) | May 6, 2004 | May 24, 2005 |
| NCT00761527 | Completed | Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634) | March 2008 | May 2010 | |
| NCT00762983 | Completed | Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) | March 2008 | February 2009 | |
| NCT00783354 | Completed | Phase 4 | A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147) | April 1, 2003 | April 1, 2004 |
| NCT00795158 | Completed | Phase 3 | How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988) | November 2002 | January 2004 |
| NCT00795522 | Completed | Phase 4 | An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540) | July 2003 | March 2005 |
| NCT00868036 | Completed | Evaluating for Contact Allergies in Patients With Chronic Urticaria | December 2008 | January 2011 | |
| NCT00876369 | Completed | Vitamin D Levels in Subjects With Chronic Urticaria and Angioedema | September 1, 2009 | December 11, 2009 | |
| NCT00886795 | Completed | Phase 1/Phase 2 | Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy | May 2009 | March 2013 |
| NCT02576041 | Completed | Phase 4 | Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria | October 2015 | December 2015 |
| NCT01091402 | Completed | Autologous Serum Skin Test and Serum IL-18 Levels in Chronic Idiopathic Urticaria and Respiratory Allergic Diseases | January 2009 | ||
| NCT01170936 | Completed | Phase 2 | Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses | July 2010 | December 2011 |
| NCT01371877 | Completed | N/A | The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment | November 1, 2011 | September 1, 2013 |
| NCT01444196 | Completed | Phase 4 | Desloratadine 5, 10 and 20mg in Patients With Cold Urticaria | August 2009 | May 2010 |
| NCT02424799 | Completed | Phase 1 | Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264 | November 17, 2014 | November 10, 2017 |
| NCT02392624 | Completed | Phase 4 | A Study of the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria | May 18, 2015 | March 9, 2017 |
| NCT01897428 | Completed | Phase 1 | PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg | April 2011 | August 2011 |
| NCT01916967 | Completed | Phase 3 | An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201) | August 27, 2013 | March 13, 2014 |
| NCT01940393 | Completed | Phase 4 | Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria | August 2013 | January 2014 |
| NCT02238249 | Completed | Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With Urticaria | October 2005 | ||
| NCT01987947 | Completed | Phase 2 | A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria | December 2013 | October 2014 |
| NCT06210698 | Not yet recruiting | Angioedema Biomarker Research Study | January 15, 2024 | February 1, 2026 | |
| NCT05330637 | Recruiting | Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China. | March 3, 2022 | April 30, 2025 | |
| NCT05936567 | Recruiting | Phase 2 | Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria | July 31, 2023 | September 5, 2025 |
| NCT05497596 | Recruiting | N/A | The Association Between Human Microbiome and Vitamin D in Chronic Urticaria | August 2, 2022 | March 31, 2025 |
| NCT03545464 | Recruiting | Phase 3 | COrticosteroids in acUte uRticAria in emerGency dEpartment | September 21, 2019 | September 21, 2025 |
| NCT00069329 | Terminated | Phase 1/Phase 2 | Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease | September 2003 | April 2010 |
| NCT02382562 | Terminated | N/A | Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria Patients | May 2015 | October 17, 2016 |
| NCT01008592 | Terminated | The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism | April 2009 | September 2010 | |
| NCT00751166 | Terminated | Phase 4 | A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736) | March 1, 2004 | May 1, 2005 |
| NCT00216762 | Terminated | Phase 1/Phase 2 | Safety Study of Rituximab (Rituxan®) in Chronic Urticaria | January 2006 | May 2007 |
| NCT03069495 | Terminated | Role of Circulating Innate Lymphoid Cells in Allergic Disorders | August 21, 2017 | February 24, 2020 | |
| NCT00199251 | Terminated | Phase 3 | Efficacy and Safety of Rupatadine 10 and 20 Mg in Chronic Idiopathic Urticaria | April 2004 | June 2005 |
| NCT00199238 | Terminated | Phase 2 | Efficacy of Rupatadine 5, 10 and 20 mg in Chronic Idiopathic Urticaria | October 28, 2002 | September 27, 2004 |
| NCT00189878 | Terminated | Phase 2 | A Study of the Use of Methotrexate in the Treatment of Chronic Idiopathic Urticaria | August 2003 | August 2008 |
| NCT03693625 | Terminated | Phase 2 | A Study to Evaluate the Long-term Safety and Efficacy of Fenebrutinib in Participants Previously Enrolled in a Fenebrutinib Chronic Spontaneous Urticaria (CSU) Study | September 27, 2018 | October 23, 2019 |
| NCT00129415 | Terminated | Phase 1/Phase 2 | Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions | August 2000 | January 2011 |
| NCT01759693 | Unknown status | Platelet Activation in Chronic Inflammatory Skin Diseases | February 2013 | October 2013 | |
| NCT01805635 | Unknown status | PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases | February 2013 | April 2014 | |
| NCT03991845 | Unknown status | Phase 4 | A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria | June 21, 2019 | December 28, 2019 |
| NCT04938700 | Unknown status | Phase 4 | Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children | March 1, 2020 | December 1, 2023 |
| NCT00346606 | Unknown status | Phase 4 | The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria | January 2006 | |
| NCT05115136 | Unknown status | Phase 3 | Using Doxepin for Urticaria | May 23, 2022 | July 1, 2023 |
| NCT02873364 | Unknown status | Phase 3 | High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria | August 2016 | January 2017 |
| NCT02550080 | Unknown status | Phase 4 | Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome | July 2015 | May 2019 |
| NCT00163839 | Unknown status | N/A | The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema | September 2005 | |
| NCT02191072 | Unknown status | N/A | Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria | July 2014 | May 2016 |
| NCT02742805 | Withdrawn | Phase 4 | Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation | February 2016 | December 2019 |
- Disase is a (Disease Ontology)
- DOID:37
- Cross Reference ID (Disease Ontology)
- ICD9CM:708.8
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:267817001
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0029839
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001025
- ICD10 preferred id (Insert disease from ICD10)
- D0009786
- ICD10 class code (Insert disease from ICD10)
- L50
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014581